Hollanders W, Harbers A H, Huige J C, Monster P, Rambags P G, Hendrikx W M
MSD AgVet, Steenweg op Waterloo, Brussels, Belgium.
Vet Parasitol. 1995 May;58(1-2):117-27. doi: 10.1016/0304-4017(94)00705-h.
The behaviour of fattening pigs, the occurrence of erythematous papular dermatitis in pigs at slaughter and the effects of treatment for mange with ivermectin at the start of the fattening period were evaluated at ten farms. At each farm, trial pigs were randomly allotted to a control or a treated group. At the start of the trial, the control group was injected intramuscularly with 5 mg kg-1 levamisole, and the treated group was injected subcutaneously with 300 micrograms kg-1 ivermectin. Skin scrapings, taken from each pig before medication at the start of the trial, and at slaughter, were examined for presence of sarcoptic mites. Pig behaviour was monitored at 2 week intervals from Week 5 to Week 13 of the trial. Carcasses of trial pigs were inspected for dermatitis at slaughter. Low to moderate Sarcoptes scabiei var. suis infestations were demonstrated at the start of the trial on five farms (S+ farms). At slaughter, the mean percentage of Sarcoptes-positive pigs per pen on S+ farms was 34.8% (range 11-60%) for the control group as compared with 0.5% (range 0-2.7%) for the ivermectin-treated group (P < 0.01). No S. scabiei was recovered from any pig at any time from the five other farms (mange-free (S-) farms). The low initial levels of mange in the controls at S+ farms resulted in a consistently high scratching index. Ivermectin treatment resulted in a significantly (P < 0.01) lower prevalence of scratching, comparable with the prevalence observed at S- farms. High prevalences of generalized dermatitis at slaughter were observed in control pigs from all S+ farms. Ivermectin treatment resulted in much lower prevalences, reflected in a significantly (P < 0.01) lower grand mean dermatitis index per pen for this group as compared with the controls. The majority of pigs from both treatment groups at all S- farms were free of papular lesions. These results indicate that low levels of sarcoptic mange at the start of fattening, left untreated, will result in a high prevalence of scratching during the fattening period and high prevalences of Sarcoptes and dermatitis at slaughter. Treatment with ivermectin at the start of fattening results in behaviour and dermatitis prevalences similar to those observed in mange-free herds.
在10个农场对育肥猪的行为、屠宰时猪身上红斑丘疹性皮炎的发生情况以及育肥期开始时用伊维菌素治疗疥螨病的效果进行了评估。在每个农场,试验猪被随机分配到对照组或治疗组。试验开始时,对照组猪肌肉注射5 mg kg-1的左旋咪唑,治疗组猪皮下注射300微克 kg-1的伊维菌素。在试验开始用药前以及屠宰时,从每头猪身上采集皮肤刮屑,检查是否存在疥螨。从试验第5周开始至第13周,每隔2周监测一次猪的行为。在屠宰时检查试验猪的胴体是否有皮炎。试验开始时,在5个农场(S+农场)发现了低至中度的猪疥螨感染。屠宰时,S+农场对照组每栏中疥螨阳性猪的平均百分比为34.8%(范围为11 - 60%),而伊维菌素治疗组为0.5%(范围为0 - 2.7%)(P < 0.01)。在另外5个农场(无疥螨(S-)农场),任何时候从任何猪身上都未检出猪疥螨。S+农场对照组疥螨的初始感染水平较低,导致抓挠指数一直很高。伊维菌素治疗使抓挠发生率显著降低(P < 0.01),与在S-农场观察到的发生率相当。在所有S+农场的对照猪中,屠宰时普遍存在全身性皮炎。伊维菌素治疗使皮炎发生率大大降低,这一组每栏的总体皮炎指数与对照组相比显著降低(P < 0.01)。所有S-农场两个治疗组的大多数猪都没有丘疹病变。这些结果表明,育肥期开始时疥螨感染水平较低,若不进行治疗,会导致育肥期抓挠发生率很高,以及屠宰时疥螨感染率和皮炎发生率很高。育肥期开始时用伊维菌素治疗,其行为和皮炎发生率与在无疥螨猪群中观察到的相似。